Imad Shureiqi
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism 14
- Cancer Genomics and Diagnostics 9
- Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology 7
- Pharmacology top 0.5%
- Inflammatory mediators and NSAID effects 26
- Toxicology top 1%
- Oncology top 2%
- Colorectal Cancer Treatments and Studies 19
-
- Estrogen and related hormone effects 14
-
- Peroxisome Proliferator-Activated Receptors 12
-
- Genetic factors in colorectal cancer 10
- Co-authors
- Scott M. LippmanXiangsheng ZuoSusan M. FischerJeffrey S. MorrisYuanqing WuPeiying YangRobert A. NewmanMicheline J. Moussalli
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)Nature Communications (2 papers)
- Partner nations
- United StatesChinaThailand
In The Last Decade
Imad Shureiqi
80 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Cancer Research 914
- Biochemistry 422
- Pharmacology 970
- Toxicology 142
- Oncology 1.0k
Countries citing papers authored by Imad Shureiqi
This map shows the geographic impact of Imad Shureiqi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imad Shureiqi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imad Shureiqi more than expected).
Fields of papers citing papers by Imad Shureiqi
This network shows the impact of papers produced by Imad Shureiqi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imad Shureiqi. The network helps show where Imad Shureiqi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Imad Shureiqi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 45 | |
| 2 | 2022 | 9 | |
| 3 | 2022 | 27 | |
| 4 | 2022 | 5 | |
| 5 | 2021 | 8 | |
| 6 | 2021 | 4 | |
| 7 | 2019 | 45 | |
| 8 | 2019 | 2 | |
| 9 | 2015 | 18 | |
| 10 | 2015 | 33 | |
| 11 | Fusobacterium in Colonic Flora and Molecular Features of Colorectal Carcinomabreakdown → | 2014 | 354 |
| 12 | 2012 | 19 | |
| 13 | 2012 | 35 | |
| 14 | 2011 | 37 | |
| 15 | 2010 | 46 | |
| 16 | 2008 | 20 | |
| 17 | 2005 | 98 | |
| 18 | 2002 | 19 | |
| 19 | 2000 | 49 | |
| 20 | 1999 | 144 |
About Imad Shureiqi
Imad Shureiqi is a scholar working on Toxicology, Cancer Research and Pharmacology, having authored 80 papers that have together received 3.6k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (26 papers), Colorectal Cancer Treatments and Studies (19 papers), Cancer, Lipids, and Metabolism (14 papers), Estrogen and related hormone effects (14 papers), Peroxisome Proliferator-Activated Receptors (12 papers), Genetic factors in colorectal cancer (10 papers), Cancer Genomics and Diagnostics (9 papers) and Eicosanoids and Hypertension Pharmacology (7 papers). The work is most often cited by research in Cancer Research (914 citations), Biochemistry (422 citations) and Pharmacology (970 citations). Imad Shureiqi has collaborated with scholars based in United States, China and Thailand. Frequent co-authors include Scott M. Lippman, Xiangsheng Zuo, Susan M. Fischer, Jeffrey S. Morris, Yuanqing Wu, Peiying Yang, Robert A. Newman, Micheline J. Moussalli, Dongning Chen and Reuben Lotan. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.